EIF3A and metabolic dysfunction-associated steatotic liver disease: Analyses of human study databases showed that eIF6 levels increase in NAFLD progression, unlike structural proteins of the small and large ribosomal subunits, while eIF1, eIF4B and eIF3A levels decrease.